LUNG EBITDA Growth
Pulmonx Corp · EBITDA Growth
LUNG EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported19.79%period ending
LUNG TTM EBITDA YoY % (-61.04% → 19.79%)
Year-over-year change
High-resolution chart · PNG
LUNG ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 19.7903% | |
| 9.7843% | |
| 0.3222% | |
| -4.3949% | |
| -2.5168% | |
| -1.0072% | |
| 8.1186% | |
| 9.0423% | |
| 7.4878% | |
| 4.6899% | |
| 1.0716% | |
| -2.4645% | |
| -9.9686% | |
| -11.6509% | |
| -21.5874% | |
| -28.6593% | |
| -43.8432% | |
| -46.7351% | |
| -61.9369% | |
| -82.3625% | |
| -45.0607% | |
| -82.1411% | |
| -61.0432% |